Skip to main

Posts & Investments - #helpeveryone

Currently I am absolutely frustrated that I finally was able to get my ability to chat all my pub buds up again... And now an unknown (at the moment) amount of errors🙀 has unfortunately🙀 struck our portfolios🙀 and our totals into an absolute mess of confusion and has us all saying #whatinthefrackisgoingonupinhere I am hoping that this can all get figured out ASAP🥺 As of now I have zero abilitSee more
Invested in NexImmune
Close to Home, lost my kids father to cancer Sept 2020 at age 38 leaving 7 kids without a father. #investedforfuturefamilies #cancersucks #cancerkills #forthefuture #curecancer2022 •Neximmune, to Participate in, " The Leukemia & Lymphoma Society Therapy Acceleration Program® (LLS TAP) Panel," on,“Expanding the Possible with Next-Generation Cell Therapies.” •Source: NexImmune, Inc. Jan.18th,2022 •About NexImmune: ~NexImmune is a: "Clinical-Stage Biotechnology Company." Developing a novel approach to IMMUNOTHERAPY designed to employ the BODY'S OWN T- CELLS to GENERATE a SPECIFIC, POTENT, and DURABLE IMMUNE RESPONSE. The backbone of NexImmune’s approach is a: "Proprietary Artificial Immune Modulation (AIM™) Nanoparticle Technology Platform." The AIM technology enables NexImmune to CONSTRUCT NANOPARTICLES that FUNCTION as SYNTHETIC DENDRITIC CELLS CAPABLE of DIRECTING a SPECIFIC T-CELL MEDIATED IMMUNE RESPONSE. AIM constructed nanoparticles EMPLOY NATURAL BIOLOGY to ENGAGE, ACTIVATE and EXPAND ENDOGENOUS T CELLS in ways that COMBINE anti-tumor attributes of antigen-specific PRECISION, POTENCY and LONG-TERM PERSISTENCE with REDUCED POTENTIAL for off-target toxicities. ++READ MORE DETAILS IN LINK! ++COMING MEETING JAN.21ST,2022 WORTH TAKING A LOOK AT! #helpeveryone #giveback #giveandgain #community #investinacause #2022 #growth #possibilities
Invested in OppFi
Added Dogecoin to long-term portfolio
#helpeveryone supplement my retirement.
Own your future.
Build your portfolio.
Contact Us
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2023 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

Brokerage services for US-listed, registered securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings, Inc. (“Public Holdings”). This is not an offer, solicitation of an offer, or advice to buy or sell securities or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured. Apex Clearing Corporation, our clearing firm, has additional insurance coverage in excess of the regular SIPC limits. Additional information can be found here

Brokerage services for alternative assets available on Public are offered by Dalmore Group, LLC (“Dalmore”), member of FINRA & SIPC. “Alternative assets,” as the term is used at Public, are equity securities that have been issued pursuant to Regulation A of the Securities Act of 1933 (as amended) (“Regulation A”). This content is not investment advice. These investments are speculative, involve substantial risks (including illiquidity and loss of principal), and are not FDIC or SIPC insured. Alternative Assets purchased on the Public platform are not held in an Open to the Public Investing brokerage account and are self-custodied by the purchaser. The issuers of these securities may be an affiliate of Public, and Public (or an affiliate) may earn fees when you purchase or sell Alternative Assets. For more information on risks and conflicts of interest, see these disclosures. An affiliate of Public may be “testing the waters” and considering making an offering of securities under Tier 2 of Regulation A. No money or other consideration is being solicited and, if sent in response, will not be accepted. No offer to buy securities can be accepted, and no part of the purchase price can be received, until an offering statement filed with the SEC has been qualified by the SEC. Any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of acceptance given after the date of qualification by the SEC or as stated in the offering materials relating to an investment opportunity, as applicable. An indication of interest to purchase securities involves no obligation or commitment of any kind.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures, Apex Crypto.

Dalmore and Apex Crypto, LLC are not affiliated with any of the Public Holdings subsidiaries. Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S.-listed, registered securities electronically during the Regular Trading Hours. Keep in mind that other fees such as regulatory fees, Premium subscription fees, commissions on trades during extended trading hours, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

Fractional shares are illiquid outside of Public and not transferable. For a complete explanation of conditions, restrictions and limitations associated with fractional shares, see our Fractional Share Disclosure to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.